Connection
Xuming Zhang to Antiviral Agents
This is a "connection" page, showing publications Xuming Zhang has written about Antiviral Agents.
|
|
Connection Strength |
|
 |
|
 |
|
1.391 |
|
|
|
-
Pechous RD, Malaviarachchi PA, Banerjee SK, Byrum SD, Alkam DH, Ghaffarieh A, Kurten RC, Kennedy JL, Zhang X. An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy. J Virol. 2024 Jul 23; 98(7):e0079424.
Score: 0.842
-
Cao J, Forrest JC, Zhang X. A screen of the NIH Clinical Collection small molecule library identifies potential anti-coronavirus drugs. Antiviral Res. 2015 Feb; 114:1-10.
Score: 0.434
-
Yang T, Li S, Zhang X, Pang X, Lin Q, Cao J. Resveratrol, sirtuins, and viruses. Rev Med Virol. 2015 Nov; 25(6):431-45.
Score: 0.115